Jack Higgins's most recent trade in Immunome Inc was a trade of 5,200 Common Stock done at an average price of $1.4 . Disclosure was reported to the exchange on March 27, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Immunome Inc | Jack Higgins | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.35 per share. | 27 Mar 2025 | 5,200 | 18,729 | - | 1.4 | 7,020 | Common Stock |
| Immunome Inc | Jack Higgins | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Mar 2025 | 5,200 | 173,840 | - | - | Employee Stock option (right to buy) | |
| Immunome Inc | Jack Higgins | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 19,524 | 179,040 | - | - | Stock option (right to buy) | |
| Immunome Inc | Jack Higgins | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.35 per share. | 15 Aug 2024 | 19,524 | 19,524 | - | 1.3 | 26,357 | Common Stock |
| Immunome Inc | Jack Higgins | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 13.93 per share. | 15 Aug 2024 | 3,524 | 16,000 | - | 13.9 | 49,072 | Common Stock |
| Immunome Inc | Jack Higgins | Chief Scientific Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 15 Aug 2024 | 2,471 | 13,529 | - | 0 | Common Stock | |
| Immunome Inc | Jack Higgins | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2024 | 190,000 | 190,000 | - | - | Stock option (right to buy) | |
| Immunome Inc | Jack Higgins | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2023 | 200,000 | 200,000 | - | - | Stock option (right to buy) |